LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Clinical trial NCT03244020 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03244020
Sponsor: Massachusetts General Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Sarcoma Soft Tissue Sarcoma Bone Sarcoma Bone Metastases Venous Thromboembolism Hematoma Anticoagulant-induced Bleeding

Start date: 2018-02-16
Primary completion: 2027-12-31
Enrollment: 2868

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.